Effects of Intramuscular Parecoxib Administration on Vasospasm in an Experimental Subarachnoid Hemorrhage Model

REFERENCES

• Aihara, Y., Kasuya, H., Onda, H., Hori, T., & Takeda, J. (2001). Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke, 32(1), 212–217.
   PubMedGoogle Scholar
• Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990). Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proceedings of the National Academy of Sciences U S A, 87(4), 1620–1624.
   Google Scholar
• Biller, J., Godersky, J. C., & Adams, H. P. Jr. (1988). Management of aneurysmal subarachnoid hemorrhage. Stroke, 19(10), 1300–1305.
   PubMedGoogle Scholar
• Borel, C. O., McKee, A., Parra, A., Haglund, M. M., Solan, A., Prabhakar, V., (2003). Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage. Stroke, 34(2), 427–433.
   PubMedGoogle Scholar
• Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., (2005). Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators: Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. New England Journal of Medicine, 352(11), 1092–10102.
   PubMed Web of Science ®Google Scholar
• Dembo, G., Park, S. B., & Kharasch, E. D. (2005). Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans. Anesthesiology, 102(2), 409–415.
   PubMedGoogle Scholar
• DeWitt, D. L., & Smith, W. L. (1988). Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proceedings of the National Academy of Sciences U S A, 85(5), 1412–1416.
   Google Scholar
• Dietrich, H. H., & Dacey, R. G. Jr. (2000). Molecular keys to the problems of cerebral vasospasm. Neurosurgery, 46(3), 517–530.
   PubMedGoogle Scholar
• Dumont, A. S., Dumont, R. J., Chow, M. M., Lin, C. L., Calisaneller, T., Ley, K. F., (2003). Cerebral vasospasm after subarachnoid hemorrhage: Putative role of inflammation. Neurosurgery, 53(1), 123–135.
   PubMed Web of Science ®Google Scholar
• Fassbender, K,. Hodapp, B., Rossol, S., Bertsch, T., Schmeck, J., Schütt, S., (2001) Inflammatory cytokines in subarachnoid haemorrhage: Association with abnormal blood flow velocities in basal cerebral arteries. Journal of Neurology, Neurosurgery, and Psychiatry, 70(4), 534–537.
   PubMedGoogle Scholar
• Garavito, R. M., & DeWitt, D. L. (1999). The cyclooxygenase isoforms: Structural insights into the conversion of arachidonic acid to prostaglandins. Biochimica et Biophysica Acta, 23, 1441(2–3), 278–287.
   Google Scholar
• Gulsen, S., Inci, S., Yuruk, S., Yasar, U., & Ozgen, T. (2007). Effect of Raloxifene on cerebral vasospasm following experimental subarachnoid hemorrhage in rats. Neurologia Medico-Chirurgica (Tokyo), 47(12), 537–542.
   PubMedGoogle Scholar
• Harrod, C. G., Bendok, B. R., & Batjer, H. H. (2005). Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: A review. Neurosurgery, 56(4), 633–654.
   PubMed Web of Science ®Google Scholar
• Herschman, H. R. (1996). Prostaglandin synthase 2. Biochimica et Biophysica Acta, 5, 1299(1), 125–140.
   Google Scholar
• Hino, A., Tokuyama, Y., Weir, B., Takeda, J., Yano, H., Bell, G. I., (1996). Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys. Neurosurgery, 39(3), 562–568.
   PubMedGoogle Scholar
• Hirashima, Y., Nakamura, S., Endo, S., Kuwayama, N., Naruse, Y., & Takaku, A. (1997). Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. Neurochemical Research, 22(10), 1249–1255.
   PubMedGoogle Scholar
• Kamii, H., Kato, I., Kinouchi, H., Chan, P. H., Epstein, C. J., Akabane, A., (1999). Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase. Stroke, 30(4), 867–872.
   PubMedGoogle Scholar
• Kelsen, J., Kjaer, K., Chen, G., Pedersen, M., Røhl, L., Frøkiaer, J., (2006). Parecoxib is neuroprotective in spontaneously hypertensive rats after transient middle cerebral artery occlusion: A divided treatment response? Journal of Neuroinflammation 6, 3, 31.
   PubMedGoogle Scholar
• Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., & Herschman, H. R. (1991). TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. Journal of Biological Chemistry, 266(20), 12866–12872.
   PubMed Web of Science ®Google Scholar
• La Grenade, L., Lee, L., Weaver, J., Bonnel, R., Karwoski, C., Governale, L., (2005). Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. Drug Safety, 28(10), 917–924.
   PubMed Web of Science ®Google Scholar
• Mayberg, M. R., Batjer, H. H., Dacey, R., Diringer, M., Haley, E. C., Heros, R. C., (1994) Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke, 25(11), 2315–2328.
   PubMed Web of Science ®Google Scholar
• McGirt, M. J., Parra, A., Sheng, H., Higuchi, Y., Oury, T. D., Laskowitz, D. T., (2002). Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke, 33(9), 2317–2323.
   PubMedGoogle Scholar
• Medele, R. J., Stummer, W., Reulen, H. J., & Steiger, H. J. (1996). Evidence for peroxidative damage by nitric oxide in experimental chronic cerebral vasospasm. Neurological Research, 18(3), 277–280.
   PubMed Web of Science ®Google Scholar
• Moodley, I. (2008). Review of the cardiovascular safety of COXIBs compared to NSAIDS. Cardiovascular Journal of Africa, 19(2), 102–107.
   PubMedGoogle Scholar
• Osuka, K., Suzuki, Y., Watanabe, Y., Takayasu, M., Yoshida, J., & Busija, D. W. (1998). Inducible cyclooxygenase expression in canine basilar artery after experimental subarachnoid hemorrhage. Stroke, 29(6), 1219–1222.
   PubMedGoogle Scholar
• Ray, W. A., Griffin, M. R., & Stein, C. M. (2004). Cardiovascular toxicity of valdecoxib. New England Journal of Medicine, 351(26), 2767.
   PubMed Web of Science ®Google Scholar
• Rimarachin, J. A., Jacobson, J. A., Szabo, P., Maclouf, J., Creminon, C., & Weksler B. B. (1994). Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 14(7), 1021–1031.
   Google Scholar
• Sayama, T., Suzuki, S., & Fukui, M. (1999). Role of inducible nitric oxide synthase in the cerebral vasospasm after subarachnoid hemorrhage in rats. Neurological Research, 21(3), 293–298.
   PubMed Web of Science ®Google Scholar
• Seifert, V., Stolke, D., Kaever, V., & Dietz, H. (1987). Arachidonic acid metabolism following aneurysm rupture. Evaluation of cerebrospinal fluid and serum concentration of 6-keto-prostaglandin F1 alpha and thromboxane B2 in patients with subarachnoid hemorrhage. Surgical Neurology, 27(3), 243–252.
   PubMedGoogle Scholar
• Sercombe, R., Dinh, Y. R., & Gomis, P. (2002) Cerebrovascular inflammation following subarachnoid hemorrhage. Japanese Journal of Pharmacology, 88(3), 227–249.
   PubMedGoogle Scholar
• Takizawa, T., Tada, T., Kitazawa, K., Tanaka, Y., Hongo, K., Kameko, M., (2001). Inflammatory cytokine cascade released by leukocytes in cerebrospinal fluid after subarachnoid hemorrhage. Neurological Research, 23(7), 724–730.
   PubMed Web of Science ®Google Scholar
• Talhari, C., Lauceviciute, I., Enderlein, E., Ruzicka, T., & Homey, B. (2005). COX-2-selective inhibitor valdecoxib induces severe allergic skin reactions. Journal of Allergy and Clinical Immunology, 115(5), 1089–1090.
   PubMedGoogle Scholar
• Tran Dinh, Y. R., Jomaa, A., Callebert, J., Reynier-Rebuffel, A. M., Tedgui, A., Savarit, A., (2001). Overexpression of cyclooxygenase-2 in rabbit basilar artery endothelial cells after subarachnoid hemorrhage. Neurosurgery, 48(3), 626–633.
   PubMed Web of Science ®Google Scholar
• Walker, V., Pickard, J. D., Smythe, P., Eastwood, S., & Perry, S. (1983). Effects of subarachnoid haemorrhage on intracranial prostaglandins. Journal of Neurology, Neurosurgery, and Psychiatry, 46(2), 119–125.
   PubMedGoogle Scholar
• Widenka, D. C., Medele, R. J., Stummer, W., Bise, K., & Steiger, H. J. (1999) Inducible nitric oxide synthase: A possible key factor in the pathogenesis of chronic vasospasm after experimental subarachnoid hemorrhage. Journal of Neurosurgery, 90(6), 1098–1104.
   PubMedGoogle Scholar
• Winder, S. J., Allen, B. G., Clément-Chomienne, O., & Walsh, M. P. (1998). Regulation of smooth muscle actin-myosin interaction and force by calponin. Acta Physiologica Scandinavica, 164(4), 415–426.
   PubMedGoogle Scholar
• Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., & Simmons, D. L. (1991). Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proceedings of the National Academy of Sciences U S A, 88(7), 2692–2696.
   PubMed Web of Science ®Google Scholar
• Ziemer, M., Wiesend, C. L., Vetter, R., Weiss, J., Blaschke, S., Norgauer, J., (2007). Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis. Archives of Dermatology, 143(6), 711–716.
   PubMedGoogle Scholar